Objective: To examine the prevalence of hospitalized myasthenia gravis (MG), and to
determine the factors associated with poor outcomes of hospitalized MG patients at a …

Background Myasthenia gravis (MG) in elderly populations is increasing. This study aimed
to evaluate predictors for treatment outcomes in elderly hospitalized MG patients using the …

Objectives To compare the burden of illness for refractory and non‐refractory myasthenia
gravis (MG) in Japanese patients. Methods Adults in a large Japanese health insurance …

Introduction Myasthenia gravis (MG) is a chronic neuromuscular disease leading to
significant disease burden. This study aimed to investigate the epidemiology of MG in …

Objective This is the first cross-region epidemiological study of myasthenia gravis (MG) in
China. We estimated the incidence, prevalence, and medical costs of MG in southern China …

Methods: Using a retrospective analysis of cross sectional survey, we determined the rates
of occurrence, in-hospital outcomes, and mean hospital charges for patients hospitalized …

Objective: To analyze the mortality and potential risk factors for death in myasthenia gravis
(MG) patients. Materials and Methods: A total of 2195 adult patients with MG (aged older …

Background: Myasthenia gravis (MG) is a rare neurological disorder, which can be life
threatening. Although death is a rare outcome, evidence does not exist as to whether …

Introduction: This study assessed the clinical burden of refractory myasthenia gravis (MG),
relative to nonrefractory MG. Methods: Rates of myasthenic crises, exacerbations, inpatient …

We performed a community-based survey of 165 Australian patients with a physician-
confirmed diagnosis of myasthenia gravis (MG). MG is an autoimmune disease of the …